Arthrosamid Treatment for Morning Stiffness in Knee Osteoarthritis

Miss Sophie Harris
Miss Sophie Harris
Published at: 1/4/2026

Arthrosamid Treatment for Morning Stiffness in Knee Osteoarthritis

Introduction

For many people living with stiffness-dominant knee osteoarthritis (OA), the morning “start-up” stiffness can be one of the most frustrating symptoms. That first movement after waking can feel slow and stiff, making it harder to get going and limiting flexibility. This stiffness can delay daily activities and affect overall quality of life. In this article, we’ll explore how Arthrosamid, a specialised treatment, can help ease that morning rigidity and support smoother, more comfortable movement. We’ll look at the nature of stiffness-dominant knee OA, explain how Arthrosamid works, share clinical findings, and consider expert perspectives and tailored patient care.

Understanding Stiffness-Dominant Knee Osteoarthritis: The Morning Start-Up Challenge

Knee osteoarthritis affects many people in different ways, but for some, stiffness is the main issue, rather than pain. This stiffness is often most noticeable after rest — especially first thing in the morning — and can make those initial steps feel awkward and difficult. When the knee joint is still after a long period of inactivity, the lubricating fluid inside it may not be spread evenly. This causes the joint to feel stiff until it “warms up” with movement.

This morning stiffness can disrupt patients’ routines by making it harder to take those easier first steps, sustain flexibility, and get moving promptly. The sensation can be disheartening and affect confidence in using the knee throughout the day.

How Arthrosamid Works to Relieve Stiffness: What the Science Says

Arthrosamid is an innovative treatment designed to support the knee joint. It is a clear, gel-like polymer that is injected directly into the joint space, where it interacts with surrounding tissues to improve joint function. By supplementing the knee’s natural lubrication, Arthrosamid helps the joint’s fluid mechanics to work more smoothly, which can reduce stiffness — especially the kind that builds up after inactivity.

Recent research adds weight to Arthrosamid’s potential. A 2025 study following patients over two years found that “PAAG provided improvement in knee OA symptoms over 24 months, particularly in older, non-diabetic patients with lower KL grades.” This suggests Arthrosamid may be especially helpful for certain groups experiencing morning stiffness. However, the authors also note that “further studies are warranted to validate efficacy, refine patient selection, and evaluate long-term impact.” Leading UK experts acknowledge Arthrosamid as a useful option alongside other treatments, particularly for improving early-day mobility.

Insights from the Clinic: Expert Views and Supportive Care Environments

Professor Paul Lee is a highly respected figure in knee orthopaedics and cartilage health. As a Regional Surgical Ambassador and advisor to the Royal College of Surgeons of Edinburgh, his wealth of clinical experience informs an evidence-based, patient-focused approach to managing stiffness-dominant knee OA.

At MSK Doctors, patients benefit from a highly professional and compassionate environment that emphasises whole-person recovery. Their team tailors treatment strategies to the specific challenges that morning stiffness brings.

Helping Patients Take Control: Tailored Treatments for Stiffness-Dominant OA

Many patients find their stiffness — rather than pain — is the main hurdle in managing their knee OA. Arthrosamid is emerging as a promising option for those who feel other treatments focus too much on pain relief. The recent patient-reported outcomes study highlights key factors linked to better results, including “being older, having a lower knee OA grade, not having diabetes, and experiencing bilateral rather than unilateral knee OA,” which can inform more personalised treatment plans.

It’s important for patients to have open conversations with experienced orthopaedic professionals who understand these nuances. Discussing morning stiffness openly can help ensure treatment is suited to individual needs, potentially including Arthrosamid alongside other therapies. Clinics like MSK Doctors, led by experts such as Professor Paul Lee, exemplify this personalised and professional approach to care.

Conclusion: Moving Towards Easier, More Comfortable Mornings

In sum, Arthrosamid offers a targeted way to ease the morning start-up stiffness that many with stiffness-dominant knee osteoarthritis face. When combined with expert, tailored orthopaedic care, it can help patients enjoy improved flexibility and a better start to their day. Ongoing research and clinical advances continue to improve outcomes, thanks to the dedication of skilled professionals and specialised clinics. If morning stiffness holds you back, exploring tailored solutions like Arthrosamid could make a real difference to your daily comfort and mobility.

References

  • Gao, H.C.K., Akhtar, M., Creedon, C., Nar, Ö.O., & Lee, P.Y. (2025). THE IMPACT OF PATIENT FACTORS ON THE MINIMAL CLINICALLY IMPORTANT DIFFERENCE OF ARTHROSAMID POLYACRYLAMIDE HYDROGEL INJECTION FOR KNEE OSTEOARTHRITIS: A COHORT STUDY. Osteoarthritis and Cartilage, 33(Supplement 1). https://doi.org/10.1016/j.joca.2025.02.648
  • Gao, H.C.K., Akhtar, M., Creedon, C., Nar, Ö.O., Verma, T., & Lee, P.Y.F. (2025). Polyacrylamide hydrogel injections in knee osteoarthritis: A PROMs-based 24 month cohort study. Journal of Clinical Orthopaedics and Trauma, 37, 103136. https://doi.org/10.1016/j.jcot.2025.103136

Frequently Asked Questions

  • MSK Doctors offers a highly professional environment and expert, patient-focused care led by Professor Paul Lee, who is a regional surgical ambassador and cartilage specialist. The clinic emphasises personalised treatment strategies, addressing the unique challenges of morning stiffness in knee osteoarthritis.
  • Arthrosamid is a gel-like polymer injected into the knee joint. It supplements the natural joint lubrication, allowing smoother movement and reducing stiffness, especially after periods of inactivity. Clinical studies suggest it may be particularly helpful for certain groups of patients.
  • Professor Paul Lee is a cartilage expert, Regional Surgical Ambassador, and advisor to the Royal College of Surgeons of Edinburgh. His extensive experience ensures that all care provided at MSK Doctors is based on the latest evidence and tailored to each patient’s individual needs.
  • Personalised treatment considers the specific factors affecting each patient, such as age, OA grade, and health conditions. MSK Doctors, under Professor Lee, tailors care for better mobility and comfort, especially where stiffness dominates over pain symptoms.
  • MSK Doctors advocates for continuous research and clinical innovation. The team collaborates with national orthopaedic organisations and integrates new treatments like Arthrosamid, ensuring patients benefit from the latest advances and evidence-based approaches in their care.

Legal & Medical Disclaimer

This article is written by an independent contributor and reflects their own views and experience, not necessarily those of MSK Doctors. It is provided for general information and education only and does not constitute medical advice, diagnosis, or treatment.

Always seek personalised advice from a qualified healthcare professional before making decisions about your health. MSK Doctors accepts no responsibility for errors, omissions, third-party content, or any loss, damage, or injury arising from reliance on this material.

If you believe this article contains inaccurate or infringing content, please contact us at webmaster@mskdoctors.com.

More Articles
All Articles
Specialties